Dr. Alexandra Sowa joins 'Varney & Co.' to discuss weight-loss drugs becoming widely available and RFK Jr.'s push to ban ...

I'm cautious about Novo Nordisk's short-term prospects due to the recent selloff, but see long-term potential with high ...

A woman who waited for four years on an NHS waiting list for weight-loss support has said she believes she could have avoided ...

Many of them are on Medicaid and have become yo-yo dieters who, despite their best efforts at changing their eating habits and lifestyles, cannot seem to shed the pounds hurting their health. “They ...

Popular obesity stocks fell on Tuesday after pharma giant Eli Lilly LLY lowered its sales guidance for full-year 2024 and announced disappointing preliminary fourth-quarter sales numbers. LLY’s ...

Pharmacy professor Nicole Albanese discusses the science behind drugs like Ozempic and Wegovy, their potential to treat other ...

The first tip came into West Tennessee law enforcement about two months ago: A resident in the area was selling cheap versions of Ozempic and other weight loss drugs. According to officials with ...

or other injectable drugs, like a GLP-1 receptor agonist, to your treatment plan. If you have overweight, your doctor will usually recommend weight loss as one aspect of an overall treatment plan.

But, no matter what direction the general market takes, some stocks could stand out, potentially in 2025, and most ...